ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
32 announcements with these filters
Quick Heal Technologies Limited has allotted 1,210 equity shares following the exercise of options under its ESOP Scheme 2021. This increases the company's total issued share capital to Rs. 54.28 Crore.
Quick Heal is pivoting from a declining B2C antivirus market to Enterprise cybersecurity (Seqrite), showing early signs of recovery.
Quick Heal appointed Shailesh Shinde as Company Secretary and KMP effective October 27, 2026. The board also approved an internal auditor and nodal officer appointment.
Quick Heal Technologies Ltd reported revenue from operations of ₹64.9 Cr (-22.3% YoY) and net profit of ₹5.8 Cr (-26.6% YoY) for Q2 FY27.
Quick Heal Technologies Ltd will hold a board meeting on October 27, 2026, to approve unaudited financial results for the quarter ended September 30, 2026.
Quick Heal Technologies Ltd has filed its quarterly Shareholding Pattern for the period ended September 30, 2026, as per SEBI regulations.
Mr. Sarang Deshpande has resigned as Company Secretary and Key Managerial Personnel of Quick Heal Technologies Limited, effective on or before October 27, 2026.
Quick Heal Technologies responded to NSE's volume surveillance query, stating the trading increase is driven by market forces. No undisclosed material information exists.
Quick Heal Technologies Limited has allotted 2,431 equity shares following the exercise of options under its ESOP Scheme 2021. The post-allotment paid-up capital stands at Rs. 54.27 Crore.
Quick Heal Technologies Limited shareholders approved the re-appointment of Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, effective September 27, 2026.
Quick Heal Technologies held its 31st Annual General Meeting on September 23, 2026, to conduct business, including the adoption of financial statements and director appointments.
Quick Heal Technologies' Chief Marketing Officer, Sudhanshu Tripathi, has resigned from the company effective September 16, 2026, to pursue other professional opportunities.
Quick Heal Technologies responded to NSE's volume-spurt query, stating all Reg 30 disclosures were made. The company attributes the increase to normal market forces with no undisclosed material event.
Quick Heal Technologies Limited has allotted 9,746 equity shares following the exercise of options under its ESOP Scheme 2021. The exercise prices ranged from ₹114 to ₹122.
Quick Heal Technologies Ltd has appointed Mr. Amit Chaudhary as Vice President – Product Management. This appointment is effective from September 01, 2026.
Quick Heal Technologies Limited has shared the link to its Integrated Annual Report for FY 2025-26 and reminded shareholders to update their KYC details.
Quick Heal Technologies filed its Integrated Annual Report for FY 2025-26. The company also announced its 31st AGM scheduled for September 23, 2026.
Quick Heal Technologies Limited has scheduled its 31st Annual General Meeting for September 23, 2026. The meeting will be conducted via video conferencing with remote e-voting available.
Quick Heal Technologies Limited has approved the grant of 1,02,000 employee stock options under its ESOP Scheme 2021. These options are exercisable at ₹76 per share.
Dr. Lalit Mohan Sanagavarapu has resigned as Chief Product Officer of Quick Heal Technologies Limited, effective August 7, 2026.
Quick Heal Technologies proposed re-appointing Mr. Richard Stiennon as a Non-Executive Independent Director for a second five-year term, pending shareholder approval.
Quick Heal Technologies Ltd reported revenue from operations of ₹45 Cr (-21.3% YoY) and a net loss of ₹5.3 Cr for Q1 FY27.
Quick Heal Technologies allotted 5,332 equity shares upon the exercise of ESOPs. The allotment occurred on July 27, 2026.
Quick Heal Technologies scheduled a Board Meeting for July 30, 2026. The board will consider the unaudited financial results for the quarter ended June 30, 2026.
Quick Heal Technologies allotted 10,286 equity shares under the ESOP Scheme 2021. The allotment followed the exercise of employee stock options.
Quick Heal Technologies allotted 500 equity shares following ESOP exercises. The issuance slightly increases paid-up capital to ₹54.25 Crore, reflecting ongoing employee benefit scheme execution.
Product data sheet for Quick Heal Antivirus Pro highlighting AI-driven security features, GoDeep.AI malware hunting technology, and the SIA virtual assistant.
Quick Heal Technologies Limited filed its Annual Secretarial Compliance Report for FY2025-26. The auditor reported full compliance with SEBI regulations with no fines or observations noted.
Quick Heal is undergoing a painful structural pivot from consumer antivirus to enterprise cybersecurity, resulting in stagnant revenue and its worst-ever quarterly profitability with a ₹11 crore net loss.
Quick Heal Technologies appointed Mr. Rohit Kachroo as Senior Director for IT and Digital Transformation. He brings over 18 years of strategic experience to the role.